Oncogenic Properties of the EBV ZEBRA Protein.

Germini, Diego; Sall, Fatimata Bintou; Shmakova, Anna; Wiels, Joëlle; Dokudovskaya, Svetlana; Drouet, Emmanuel; Vassetzky, Yegor

Germini, Diego; Sall, Fatimata Bintou; Shmakova, Anna; Wiels, Joëlle; Dokudovskaya, Svetlana; Drouet, Emmanuel; Vassetzky, Yegor.

Afiliação

Germini D; CNRS UMR9018, Université Paris-Saclay, Institut Gustave Roussy, 94805 Villejuif, France.
Sall FB; CNRS UMR9018, Université Paris-Saclay, Institut Gustave Roussy, 94805 Villejuif, France.
Shmakova A; Laboratory of Hematology, Aristide Le Dantec Hospital, Cheikh Anta Diop University, Dakar 12900, Senegal.
Wiels J; CNRS UMR9018, Université Paris-Saclay, Institut Gustave Roussy, 94805 Villejuif, France.
Dokudovskaya S; CNRS UMR9018, Université Paris-Saclay, Institut Gustave Roussy, 94805 Villejuif, France.
Drouet E; CNRS UMR9018, Université Paris-Saclay, Institut Gustave Roussy, 94805 Villejuif, France.
Vassetzky Y; CIBB-IBS UMR 5075 Université Grenoble Alpes, 38044 Grenoble, France.

Cancers (Basel) ; 12(6)2020 Jun 05.

Article em En | MEDLINE | ID: mdl-32517128

Palavras-chave

BZLF1; EBV; ZEBRA; Zta; lytic cycle; oncogenesis; transactivation; transcription; viral-host interaction

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google